Analysis of immune-related adverse event by immune checkpoint inhibitor

Analysis of immune-related adverse event by immune checkpoint inhibitor - Analysis of irAE

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031806

Enrollment

180

Registered

2018-03-20

Start date

2018-03-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients treated by immune checkpoint inhibitor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients treated by immune checkpoint inhibitor in Chiba University hospital

Exclusion criteria

Exclusion criteria: Patients who are judged as being ina ppropriate for this study by their medic al doctor

Design outcomes

Primary

Measure	Time frame
the prevalence of the gastrointestinal and hepatological irAE	—

Countries

Japan

Contacts

Public ContactMakoto Arai

Chiba University Hospital Department of medical oncology

araim-cib@umin.ac.jp043-222-7171

Outcome results